VN-0103 Ph3 study -A randomized, observer-blind comparative study of VN-0103 and diphtheria-tetanus toxoid in Japanese adolescents

Trial Profile

VN-0103 Ph3 study -A randomized, observer-blind comparative study of VN-0103 and diphtheria-tetanus toxoid in Japanese adolescents

Completed
Phase of Trial: Phase III

Latest Information Update: 24 May 2016

At a glance

  • Drugs Diphtheria tetanus and pertussis vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors Daiichi Sankyo Company; Kitasato Daiichi Sankyo Vaccine
  • Most Recent Events

    • 26 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top